Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

783
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
783
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

884
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
884
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

10.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.1K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

668
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
668
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

622
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
622

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapamycin co-exposure fails to reduce cisplatin-induced damage in GC6-spg spermatogonial cell line.

Reproduction & fertility·2026
Same author

Fertility preservation in prepubertal boys: management and follow-up challenges.

Endocrine connections·2026
Same author

Machine learning and automation methods for the segmentation, classification and quantification of testicular tissue sections.

Reproduction & fertility·2026
Same author

SIRT7 links H3K36ac epigenetic regulation with genome maintenance in the mouse testis.

Nature communications·2026
Same author

Coordinating Fertility Preservation in Children and Young Adults at Risk of Treatment-Induced Infertility: A Commentary.

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

How to build a testis, cell by cell.

Science (New York, N.Y.)·2026

Related Experiment Video

Updated: Feb 3, 2026

Ex vivo Culture of Drosophila Pupal Testis and Single Male Germ-line Cysts: Dissection, Imaging, and Pharmacological Treatment
08:35

Ex vivo Culture of Drosophila Pupal Testis and Single Male Germ-line Cysts: Dissection, Imaging, and Pharmacological Treatment

Published on: September 11, 2014

18.0K

How does chemotherapy treatment damage the prepubertal testis?

Caroline M Allen1, Federica Lopes1, Rod T Mitchell2

  • 1Biomedical Sciences, University of Edinburgh, Edinburgh, UK.

Reproduction (Cambridge, England)
|November 6, 2018
PubMed
Summary

Chemotherapy can harm the prepubertal testis, impacting fertility in young boys. Research is exploring how these drugs cause damage and developing ways to protect fertility during cancer treatment.

More Related Videos

An In Vivo Method to Study Mouse Blood-Testis Barrier Integrity
05:48

An In Vivo Method to Study Mouse Blood-Testis Barrier Integrity

Published on: December 2, 2018

11.8K
Teratoma Generation in the Testis Capsule
05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

21.4K

Related Experiment Videos

Last Updated: Feb 3, 2026

Ex vivo Culture of Drosophila Pupal Testis and Single Male Germ-line Cysts: Dissection, Imaging, and Pharmacological Treatment
08:35

Ex vivo Culture of Drosophila Pupal Testis and Single Male Germ-line Cysts: Dissection, Imaging, and Pharmacological Treatment

Published on: September 11, 2014

18.0K
An In Vivo Method to Study Mouse Blood-Testis Barrier Integrity
05:48

An In Vivo Method to Study Mouse Blood-Testis Barrier Integrity

Published on: December 2, 2018

11.8K
Teratoma Generation in the Testis Capsule
05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

21.4K

Area of Science:

  • Oncology
  • Reproductive Biology
  • Pediatrics

Background:

  • Chemotherapy is vital for childhood cancer survival but causes infertility.
  • Fertility preservation options for prepubertal boys are limited.
  • Prepubertal testicular function differs from adults, requiring specific research.

Purpose of the Study:

  • To review current research on chemotherapy-induced prepubertal testicular damage.
  • To understand the mechanisms of gonadotoxicity in young males.
  • To inform the development of fertility-sparing strategies.

Main Methods:

  • Review of human and animal studies on chemotherapy effects on the prepubertal testis.
  • Analysis of direct gonadal damage mechanisms.
  • Utilizing in vivo and in vitro animal models to isolate drug effects.

Main Results:

  • Chemotherapy agents target germ cells, inducing apoptosis and potentially affecting Sertoli cells.
  • Testicular damage varies by drug, dose, schedule, and patient's age/pubertal status.
  • Animal models help define individual drug impacts often obscured by combination therapies.

Conclusions:

  • Understanding chemotherapy's impact on the prepubertal testis is crucial for patient counseling.
  • Further research can guide the development of cytoprotective agents to preserve fertility.
  • Targeted strategies are needed to mitigate long-term reproductive side effects in childhood cancer survivors.